Back to news
24 February 2021

MedApp to implement StethoMe in its app

MedApp has signed an agreement with StethoMe, a start-up developer of a solution for remote detection of respiratory abnormalities. As part of the partnership, MedApp’s digital medicine application will support a wireless stethoscope. The new device will expand the range of tests offered by medical facilities using CarnaLife System and Digital Clinic solutions.

StethoMe is the first solution for remote detection of abnormalities in the respiratory system. It is based on artificial intelligence algorithms with medical device status, working with a wireless stethoscope and adedicated application. With unique technologies to ensure the test’s quality, it can be used by patients remotely. The solution is particularly useful for people with conditions such as asthma, chronic obstructive pulmonary disease, diabetes, pneumonia, bronchitis and other respiratory conditions.

“StethoMe is one of the most innovative solutions available in the medical market today. We look forward to working together with the StethoMe team to deploy it at our partner facilities and enhance our app and services. Already, CarnaLife System and the Digital Clinic offer a wide spectrum of measurements and their analysis in the areas of internal medicine, cardiology or diabetology. With a wireless stethoscope, physicians from facilities using our solutions will be able to check the respiratory status of patients without making appointments. All remotely,” summarizes Krzysztof Mędrala, CEO of MedApp.

CarnaLife System is an advanced digital medicine platform that allows a physician to assess and monitor the health of patients with various conditions and conduct remote consultations at any time of the day and at any place. Depending on medical indications, patients under the care of staff using the CarnaLife System platform measure blood glucose levels, blood pressure, body temperature, pulse oximetry, perform ECG, etc. The platform also enables the collection of well-being data and other parameters related to the monitoring of neuropsychiatric symptoms. CarnaLife System is a module of the CarnaLife analytical system, which is certified as a Class IIb medical device. In October 2020,
MedApp introduced further extensions of the application in the form of the Digital Clinic service. It aims to improve the functioning of small medical facilities, hospitals and developed medical chains, and provide them with real support in terms of full patient service.

Download the .pdf file


Read more See similar articles: